ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Dept. of Defense opens program announcements for prostate cancer research.

December 10, 2004

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012